IntegriChain

Philadelphia, United States Founded: 2005 • Age: 21 yrs Acquired By Nordic Capital
Inventory, order and customer relationship management solution for life science suppliers.
Annual revenue $5,391 Latest available
Total funding $2.0M 4 rounds
Employees 282 Tracked headcount
Investors 6 Known backers
Products 5 Services tracked
Competitors 9 Brand Intelligence

About IntegriChain

IntegriChain is a company based in Philadelphia (United States) founded in 2005 was acquired by Nordic Capital in November 2023. IntegriChain has raised $2 million across 4 funding rounds from investors including Accel-KKR, SaaS Capital and Activate Venture Partners. The company has 282 employees as of April 07, 2024. IntegriChain has completed 4 acquisitions, including Blue Fin Group, Federal Compliance Solutions and Medical Communication Technologies. IntegriChain offers products and services including ICyte Platform, Contracts & Pricing, Gross-to-Net, Channel Insights, and Patient Access. IntegriChain operates in a competitive market with competitors including ACTO, Indegene, IMS Health, Axtria and Clinigen, among others.

  • Headquarter Philadelphia, United States
  • Employees 282 as on 07 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Integrichain Private Limited
  • Date of Incorporation 06 Jun, 2011
  • Jurisdiction Pune, Maharashtra, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $5.39 K (USD)
    -99.86
    as on Mar 31, 2023
  • Net Profit
    $395.42 (USD)
    -99.87
    as on Mar 31, 2023
  • EBITDA
    $881.03 (USD)
    -99.82
    as on Mar 31, 2023
  • Total Equity Funding
    $2 M (USD)

    in 4 rounds

  • Latest Funding Round
    Not available
  • Investors
    Accel-KKR

    & 5 more

  • Employee Count
    282

    as on Apr 07, 2024

  • Investments & Acquisitions
  • Acquired by
    Nordic Capital

    (Nov 08, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of IntegriChain

IntegriChain offers a comprehensive portfolio of products and services, including ICyte Platform, Contracts & Pricing, Gross-to-Net, Channel Insights, and Patient Access.

Product name locked
Category locked
Primary

Platform for pharmaceutical data and commercialization insights

Product name locked
Category locked
Locked

Tools for managing pharma contracts and pricing obligations

Product name locked
Category locked
Locked

Services for forecasting and managing gross-to-net revenue

Product name locked
Category locked
Locked

Analytics for product utilization and channel data

Product name locked
Category locked
Locked

Solutions for enhancing patient data and adherence

People of IntegriChain

Headcount 200-500
Employee Profiles 191
Employee Profiles
People
Clay Willis
Partner
People
Kashish Vyas
Senior Data Engineer
People
Andrés Felipe Cárdenas
Engineering Manager
People
Garkash Metkar
Technical Analyst

Unlock access to complete

Funding Insights of IntegriChain

IntegriChain has successfully raised a total of $2M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in IntegriChain

IntegriChain has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Accel-KKR, SaaS Capital and Activate Venture Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are focused on mid-market software and technology-enabled services firms.
Locked Locked Locked
Early-stage venture capital is provided by Activate Venture Partners.
Locked Locked Locked
Investments are made in early to mid-stage US companies.
Locked Locked Locked
Premium access

Investor details for IntegriChain

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by IntegriChain

IntegriChain has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Blue Fin Group, Federal Compliance Solutions and Medical Communication Technologies.

Investments
Premium access

Investment portfolio details for IntegriChain

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of government pricing and contracting advisory consulting to the life sciences industry
Locked Locked 2017 Locked
Healthcare consultancy, GPO, and management services are provided.
Locked Locked 2001 Locked
Distributor of electric valve accessories
Locked Locked 2000 Locked
Premium access

Complete acquisition details for IntegriChain

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - IntegriChain

Premium access

Detailed financials for IntegriChain

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Integrichain Comparisons

IntegriChain Primary company
Description
Inventory, order and customer relationship management soluti...
Location
Philadelphia, United States
Founded Year
2005
Annual Revenue
$5.39 K (USD)
Net Profit
$395.42 (USD)
EBITDA
$881.03 (USD)
Employees
282
As of 2024
Premium access

Peer comparison for IntegriChain

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of IntegriChain

IntegriChain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACTO, Indegene, IMS Health, Axtria and Clinigen, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI and SaaS-based educational platform for life sciences is provided.
Locked Locked Locked
Suite solutions are provided for payers and healthcare providers.
Locked Locked Locked
SaaS and AI-based market intelligence is provided for healthcare companies.
Locked Locked Locked
Data analytics and AI solutions are provided for life sciences.
Locked Locked Locked
Specialty medicines are supplied via clinical trials and access programs.
Premium access

Detailed competitors of IntegriChain

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Integrichain

Premium access

Complete news archive for IntegriChain

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IntegriChain

IntegriChain was founded in 2005 and raised its 1st funding round 1 year after it was founded.

IntegriChain is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

IntegriChain is a funded company, having raised a total of $2M across 4 funding rounds to date.

As of Apr 07, 2024, the latest employee count at IntegriChain is 282.

Annual revenue of IntegriChain is $5.39K as on Mar 31, 2023.

IntegriChain was founded in 2005 in Philadelphia, United States, focusing on the life sciences sector. Supply chain relationships, inventories, and orders are managed for healthcare suppliers across retailers, ecommerce platforms, and distributors. Tools including Demand Visibility for tracking product distribution, Scorecard for agreement management, Signals for order monitoring, and Order Planning for forecasting are offered. Additional services encompass training, custom reporting, data integration, and returns forecasting.

IntegriChain's top competitors include Indegene, Axtria and ACTO.

IntegriChain offers ICyte Platform, Contracts & Pricing, Gross-to-Net, Channel Insights, and Patient Access.

IntegriChain has made 4 acquisitions, including Blue Fin Group, Federal Compliance Solutions, and Medical Communication Technologies.

IntegriChain has 6 investors. Key investors include Accel-KKR, SaaS Capital, Activate Venture Partners, Cross Atlantic Capital Partners, and NJTC Venture Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available